Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc C.PMED

Alternate Symbol(s):  PMEDF

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Post by Hiddensecretson Aug 26, 2020 2:53pm
204 Views
Post# 31456998

Business Sales of Screening devices

Business Sales of Screening devicesTime frame to conclude sale is:       6 months to 12 months

PMED is not selling candy, they are selling a screening device.   When a business is approached with this new screening device they will want to do some due diligence first, then they will want to test it themselves to see results, then they need to decide where devices are to be put and who does the monituring in terms of personnel and, what happens when a positive outcome is noted. 

Also discussion of fees, of drafting contracts, etc...

All of this takes time.   You cannot expect PMED to walk into a Fortune 500 company and simply install their devices as if you were replacing a window. 

Management wants to make sure that device is safe, that their employees will be reception, that device is effective and efficent, that cost metrics make sense. 

Investors have this very limited view of the world thinking that management shakes a wand and magic happens.

By November or December 2020 we will begin to see the first few fruits of their sales, which will accelerate. 

When you plant seeds in your tomateo garden you do not expect tomateos the next day.  You are smart enough to give it 60 days. 

The same is here except time frame is a little longer. 

MPO
<< Previous
Bullboard Posts
Next >>